Arkolith/Insider Trading/ENTA/Form 4

Luu Brendan

Chief Business OfficerENANTA PHARMACEUTICALS INC (ENTA) · full profile →Form 4 · filed Dec 3, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 1, 2024Tax withholding(F)753$8.60$6K38K

Transaction Codes

F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001062993-24-019990) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML